Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
| 0.555 | |
| 0.525 | |
| - | |
| 0.555 | |
| 0.52 | |
| 0.41-0.655 | |
| 146 M | |
| 270 M | |
| 824 K | |
| 0.265 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
MINNEAPOLIS, January 25, 2023--(BUSINESS WIRE)--Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is p...
Insiders who purchased US$201k worth of Imricor Medical Systems, Inc. (ASX:IMR) shares over the past year recouped some of their losses after price gained 75% last week. The purchase, however, has pro...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
